Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Autoimmune Disorders

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identifying outcome measures for clinical trials in juvenile idiopathic arthritis associated uveitis for the MIWGUC proposal: a scoping review to create domains from existing outcome measures.

Pediatric rheumatology online journal·2026

Same author

Are we ready to predict progressive disease in juvenile systemic sclerosis?

Journal of scleroderma and related disorders·2026

Same author

What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohort.

Journal of scleroderma and related disorders·2026

Same author

Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposium.

Expert review of clinical immunology·2026

Same author

Serological biomarkers of JIA-associated uveitis: ANA titers, ANA AC-30 staining pattern and prefoldin 5 antibodies.

Arthritis research & therapy·2026

Same author

A post hoc analysis of BLISS-LN found Belimumab plus mycophenolate mofetil improves kidney outcomes versus placebo plus mycophenolate mofetil in active lupus nephritis.

Kidney international·2026

Same journal

Immunopathogenesis and Cytokine Pathways in Reactive Infectious Mucocutaneous Eruption (RIME) in Pediatric Population: Infectious Triggers and Molecular Insights.

Clinical reviews in allergy & immunology·2026

Same journal

Neuropsychological Factors in Vitiligo: Mechanisms and Clinical Application.

Clinical reviews in allergy & immunology·2026

Same journal

Tertiary Lymphoid Structure: A Potential Therapeutic Target Affecting Immune Response in Autoimmune Diseases.

Clinical reviews in allergy & immunology·2026

Same journal

Differentiating Acute-onset Autoimmune Hepatitis From Drug-Induced Autoimmune-like Hepatitis: A Multicenter Study and Score Development.

Clinical reviews in allergy & immunology·2026

Same journal

Mapping Neuro Behcet's Disease Across North Africa: a Systematic Review and Meta Analysis.

Clinical reviews in allergy & immunology·2026

Same journal

Early-life Gut Microbiota and Allergic Diseases: Immune Regulatory Mechanisms and Intervention Progress.

Clinical reviews in allergy & immunology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 29, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Cutting-edge issues in autoimmune uveitis.

Roger A Levy¹, Francisco Assis de Andrade, Ivan Foeldvari

¹Disciplina de Reumatologia, térreo, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Federico Foundation, Rio de Janeiro, Brazil. Roger.a.levy@gmail.com

Clinical Reviews in Allergy & Immunology

|September 14, 2011

Summary

This summary is machine-generated.

Autoimmune uveitis (AIU) is a major cause of preventable blindness. Prompt referral and advanced treatments, including biologics, are improving outcomes for this serious eye condition.

More Related Videos

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

Published on: June 7, 2017

Related Experiment Videos

Last Updated: May 29, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

Published on: June 7, 2017

Area of Science:

Ophthalmology
Immunology
Rheumatology

Background:

Autoimmune uveitis (AIU) is a significant cause of preventable vision loss.
AIU can manifest independently or alongside systemic autoimmune inflammatory diseases.
Early ophthalmological evaluation is crucial for accurate diagnosis and localized management.

Purpose of the Study:

To review the current understanding and management of autoimmune uveitis.
To highlight the role of systemic treatments and emerging biologic therapies.
To discuss the contribution of clinical and experimental models to understanding AIU pathogenesis.

Main Methods:

Literature review of autoimmune uveitis.
Analysis of clinical manifestations and systemic associations.
Evaluation of current and emerging therapeutic strategies, including corticosteroids, immunosuppressors, and biologics (anti-TNF, abatacept, tocilizumab).

Main Results:

AIU requires prompt referral for classification and treatment.
Recurrent and chronic AIU necessitate systemic therapy, often starting with corticosteroids and immunosuppressors.
Biologic agents show promise for cases refractory to conventional treatments.

Conclusions:

Advances in understanding AIU pathogenesis are driving the development of targeted therapies.
Improved treatment schemes, including biologics, are enhancing outcomes for patients with AIU.
Continued research into basic mechanisms will likely lead to even more effective future treatments for autoimmune uveitis.